Assessment of myocardial matrix expansion with cardiac magnetic resonance: Entering a new area of cardiac risk stratification in type 2 diabetes mellitus?

European Heart Journal

Volumn 35, Issue 10, 2014, Pages 608-611

  Schindler, T H ^a   Lima, J A C ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Cardiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GADOLINIUM;

AORTA STENOSIS; AORTA VALVE REPLACEMENT; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CORONARY ARTERY CALCIFICATION; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; FIBROSING ALVEOLITIS; FOLLOW UP; HEART; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE NECROSIS; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MYOCARDIAL MATRIX EXPANSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; EXTRACELLULAR MATRIX; FEMALE; HUMANS; MALE;

EID: 84898013760     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht245     Document Type: Review

References (15)

1. Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I. Eur Heart J; doi: 10.1093/eurheartj/eht149. Published online ahead of print 2 May 2013
2. Beckman JA, Paneni F, Cosentino F, Creager MA. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part II. Eur Heart J; doi: 10.1093/eurheartj/eht142. Published online ahead of print 26 April 2013
3. From AM, Scott CG, Chen HH. The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study. J Am Coll Cardiol 2010;55:300-305
4. Quercioli A, Montecucco F, Pataky Z, Thomas A, Ambrosio G, Staub C, Di Marzo V, Ratib O, Mach F, Golay A, Schindler TH. Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: Relation to alterations in endocannabinoids and adipocytokines. Eur Heart J 2013;in press
5. Nambi V, Chambless L, He M, Folsom AR, Mosley T, Boerwinkle E, Ballantyne CM. Common carotid artery intima-media thickness is as good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) study. Eur Heart J 2012;33:183-190
6. Erbel R, Budoff M. Improvement of cardiovascular risk prediction using coronary imaging: Subclinical atherosclerosis: The memory of lifetime risk factor exposure. Eur Heart J 2012;33:1201-1213
7. Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS, Mulukutla SR, Simon MA, Schelbert EB. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 2012;126:1206-1216
8. Nicholls SJ, Tuzcu EM, Kalidindi S, Wolski K, Moon KW, Sipahi I, Schoenhagen P, Nissen SE. Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: A pooled analysis of 5 intravascular ultrasound trials. J Am Coll Cardiol 2008;52:255-262
9. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 2011;57:891-903
10. Messroghli DR, Nordmeyer S, Dietrich T, Dirsch O, Kaschina E, Savvatis K,Oh-Ici D, Klein C, Berger F, Kuehne T. Assessment of diffuse myocardial fibrosis in rats using small-Animal Look-Locker inversion recovery T1 mapping. Circ Cardiovasc Imaging 2011;4:636-640
11. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004;52:141-146
12. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: Preliminary validation in humans. Circulation 2010;122:138-1344
13. Di Carli MF, Kwong RY, Jerosch-Herold M. Insights into left ventricular remodeling through noninvasive measures of myocardial matrix expansion with cardiovascular magnetic resonance. Circulation 2012;126:1179-1181
14. Wong TC, Piehler K, Kang IA, Kadakkal A, Kellman P, Schwartzman DS, Mulukutla SR, Simon MA, Shroff SG, Kuller LH, Schelbert EB. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J 2014;35: 657-664
15. Schindler TH, Dilsizian V. Cardiac positron emission tomography/computed tomography imaging of the rennin-Angiotensin system in humans holds promise for image-guided approach to heart failure therapy. J Am Coll Cardiol 2012;60: 2535-2537.